Emerging problems with plasmid-mediated DHA and CMY AmpC beta-lactamases in Enterobacteriaceae in Singapore.
Koh
Tse Hsien
TH
Sng
Li-Hwei
LH
Wang
Grace
G
Hsu
Li-Yang
LY
Lin
Raymond Tzer Pin
RT
Tee
Nancy Wen Sim
NW
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001426:Bacterial Proteins / Q000235:genetics*; D004755:Enterobacteriaceae / Q000187:drug effects / Q000201:enzymology / Q000235:genetics*; D004756:Enterobacteriaceae Infections / Q000453:epidemiology* / Q000382:microbiology; D004926:Escherichia coli / Q000187:drug effects / Q000201:enzymology / Q000235:genetics; D006801:Humans; D007711:Klebsiella pneumoniae / Q000187:drug effects / Q000201:enzymology / Q000235:genetics; D008826:Microbial Sensitivity Tests; D008969:Molecular Sequence Data; D010957:Plasmids / Q000235:genetics*; D012475:Salmonella / Q000187:drug effects / Q000201:enzymology / Q000235:genetics; D012846:Singapore / Q000453:epidemiology; D001618:beta-Lactamases / Q000235:genetics*
D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; C048795:AmpC beta-lactamases; C491823:CMY-1 beta-lactamase; D001618:beta-Lactamases; C494147:beta-lactamase DHA-1, Salmonella